Can a sleep drug fix insomnia in depressed patients?

NCT ID NCT06843187

First seen May 15, 2026 · Last updated May 15, 2026

Summary

This study tests if Lemborexant, a sleep medication, can help adults with depression who still have insomnia despite treatment. About 30 participants will take either Lemborexant or a placebo daily for 6 weeks, tracking sleep and symptoms. The goal is to see if the drug improves sleep and is practical for daily use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Michael's Hospital, Unity Health Toronto

    RECRUITING

    Toronto, Ontario, M5B 1W8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.